Brief: IX Biopharma Set To Expand Its Current Wafer Production Capacity At Facility In Australia
02/06/2021 02:58
June 2 (Reuters) - IX Biopharma Ltd IXBI.SI :
* SET TO EXPAND ITS CURRENT WAFER PRODUCTION CAPACITY AT
FACILITY
IN AUSTRALIA
* ON TRACK TO PRODUCE ITS FIRST COMMERCIAL BATCH OF WAFERS
IN JULY
2021
* WITH NEW FREEZE-DRY EQUIPMENT, CO'S PRODUCTION CAPACITY
FOR
WAFERIX SUBLINGUAL WAFERS WILL RISE BY UP TO 6 TIMES
* RECEIVED SIGNIFICANT INTEREST FROM POTENTIAL PARTNERS
LOOKING TO
DISTRIBUTE OUR WAFER PRODUCTS
Source text for Eikon: ID:nSNZb0dM6n
Further company coverage: IXBI.SI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IX Biopharma
See all newsBrief: IX Biopharma Says Co Will Undertake An Internal Restructuring Of Its Consumer Business
Brief: IX Biopharma To Issue 1 MLN New Shares To Anson Properties At S$0.4215 Per Share
Brief: IX Biopharma Says US Government Awards US$41 MLN Contract To Fund Development Of Wafermine
Brief: IX Biopharma To Raise At Least S$6 MLN Via Placement At S$0.198 Per Share
Brief: IX Biopharma Enters Term Sheet For Proposed Joint Venture